Background

Male breast cancer is a sporadic disease and only one in every 100 new breast cancer patients is male. There are few satisfactory clinical studies on male breast cancers in the literature. We aim to share the clinicopathologic and demographic characteristics of male breast cancer patients admitted to our clinic in the last 12 years and our experience in the treatment of these patients.

Methods

The data of patients who were referred to our clinic with a diagnosis of breast cancer, suspicion of breast cancer, or who presented to our outpatient clinic with symptoms of breast discharge, palpable mass in the breast and were diagnosed with breast malignancy or suspicion of malignancy between 2010 and 2022 were retrospectively evaluated from the data bank records of our hospital. 28 patients were included in the study. Patients' clinical and pathologic data, treatment options, approach to the axilla, pathology results, and survival were evaluated.

Results

There were 28 patients in the research. 22 had mastectomies. No surgical intervention was carried out for the five patients who had metastases. One of these patients died during follow-up due to advanced comorbidities and metastatic disease. Another patient declined surgery following neoadjuvant chemotherapy and passed away during follow-up (ex). The third patient passed away during neoadjuvant chemotherapy, and two patients are still undergoing neoadjuvant treatment.

Conclusion

Male breast cancers are rare diseases. RT after mastectomy increases survival in male patients as well as in female patients. However, RT in male patients is not standardized today. In our study, 15 patients received adjuvant RT.

This content is only available as a PDF.